Clinical Trial Update: An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring the combination of apatinib and S-1 in advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Changzhou Cancer Hospital of Soochow University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED